Meconium

Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb

Retrieved on: 
Wednesday, April 3, 2024

Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, is delighted to announce the commencement of a program to explore the applicable use of the INSPIRA™ ART100 Device for an artificial womb for neonates in need of vital respiratory support.

Key Points: 
  • Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, is delighted to announce the commencement of a program to explore the applicable use of the INSPIRA™ ART100 Device for an artificial womb for neonates in need of vital respiratory support.
  • Inspira aims to explore how this potential additional application of the INSPIRA ART100 device to provide neonates with vital respiratory support could replace the currently used mechanical ventilators.
  • "Inspira is dedicated to pushing the boundaries of medical technology to save and improve lives," remarked Dagi Ben-Noon, CEO of Inspira Technologies.
  • The Company's products have not yet been tested or used in humans and has not been approved by any regulatory entity.

Global Artificial Lung Devices Pipeline Insight and Competitive Landscape Report 2021: Comprehensive Insights About 20+ Companies and 23+ Pipeline Devices - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 22, 2021

b'Artificial lung device is a prosthetic device works as an alternative to the biological lung.

Key Points: 
  • b'Artificial lung device is a prosthetic device works as an alternative to the biological lung.
  • It provides oxygenation of blood and removal of carbon dioxide from the blood.
  • Artificial lung devices are made of synthetic material that are connected to blood vessels through tubes and cannulas of silicone.\nThis segment of the artificial lung devices report encloses its detailed analysis of various pipeline devices which include product description, licensing and collaboration details and other developmental activities including latest news and press releases.
  • The report also provides list of major players involved in the pipeline product development.\nArtificial lung devices for decades have been used in newborns and children with lung failure, pneumonia, meconium aspiration syndrome and other conditions.